Carnegie Investment Counsel’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$298K Sell
4,220
-30
-0.7% -$2.25K 0.01% 482
2025
Q4
$335K Hold
4,250
0.01% 461
2025
Q3
$350K Sell
4,250
-900
-17% -$70.8K 0.01% 451
2025
Q2
$414K Sell
5,150
-400
-7% -$30.9K 0.01% 424
2025
Q1
$386K Sell
5,550
-411
-7% -$34.2K 0.01% 401
2024
Q4
$488K Sell
5,961
-70
-1% -$5.83K 0.01% 343
2024
Q3
$497K Buy
6,031
+494
+9% +$36.9K 0.01% 336
2024
Q2
$389K Sell
5,537
-1,250
-18% -$89.2K 0.01% 369
2024
Q1
$503K Buy
6,787
+882
+15% +$61.5K 0.02% 355
2023
Q4
$390K Buy
5,905
+253
+4% +$15.8K 0.01% 386
2023
Q3
$356K Sell
5,652
-196
-3% -$12.2K 0.01% 386
2023
Q2
$331K Sell
5,848
-1,085
-16% -$60.2K 0.01% 411
2023
Q1
$402K Sell
6,933
-148
-2% -$9.99K 0.02% 384
2022
Q4
$512K Sell
7,081
-943
-12% -$67.5K 0.02% 348
2022
Q3
$488K Buy
8,024
+2,158
+37% +$138K 0.02% 336
2022
Q2
$368K Hold
5,866
0.02% 376
2022
Q1
$412K Buy
5,866
+468
+9% +$31.6K 0.02% 371
2021
Q4
$337K Buy
5,398
+495
+10% +$31.1K 0.01% 406
2021
Q3
$303K Sell
4,903
-229
-4% -$13.8K 0.01% 385
2021
Q2
$307K Sell
5,132
-300
-6% -$19K 0.01% 389
2021
Q1
$330K Hold
5,432
0.01% 366
2020
Q4
$255K Sell
5,432
-1,027
-16% -$44.5K 0.01% 382
2020
Q3
$240K Sell
6,459
-989
-13% -$37.5K 0.01% 372
2020
Q2
$272K Sell
7,448
-971
-12% -$33.8K 0.02% 354
2020
Q1
$257K Sell
8,419
-2,732
-25% -$121K 0.02% 339
2019
Q4
$568K Sell
11,151
-896
-7% -$43.3K 0.03% 290
2019
Q3
$568K Sell
12,047
-6,427
-35% -$306K 0.04% 277
2019
Q2
$918K Sell
18,474
-396
-2% -$18.6K 0.06% 225
2019
Q1
$803K Sell
18,870
-2,831
-13% -$125K 0.06% 235
2018
Q4
$891K Sell
21,701
-32,258
-60% -$1.38M 0.08% 199
2018
Q3
$2.38M Buy
53,959
+20,144
+60% +$920K 0.19% 125
2018
Q2
$1.52M Sell
33,815
-3,061
-8% -$143K 0.12% 166
2018
Q1
$1.73M Sell
36,876
-416
-1% -$20.2K 0.14% 145
2017
Q4
$1.73M Buy
37,292
+2,767
+8% +$146K 0.15% 163
2017
Q3
$1.84M Buy
34,525
+421
+1% +$20.5K 0.22% 120
2017
Q2
$1.69M Buy
34,104
+1,964
+6% +$91.1K 0.21% 128
2017
Q1
$1.5M Buy
32,140
+5,614
+21% +$268K 0.19% 131
2016
Q4
$1.27M Sell
26,526
-54
-0.2% -$2.48K 0.17% 136
2016
Q3
$1.11M Sell
26,580
-5,996
-18% -$225K 0.16% 141
2016
Q2
$1.25M Buy
32,576
+4,213
+15% +$164K 0.18% 139
2016
Q1
$1.11M Buy
28,363
+6
+0% +$224 0.17% 145
2015
Q4
$1.13M Buy
28,357
+881
+3% +$38.7K 0.2% 127
2015
Q3
$1.21M Buy
27,476
+6,585
+32% +$308K 0.21% 117
2015
Q2
$1.04M Buy
20,891
+9
+0% +$426 0.18% 130
2015
Q1
$939K Buy
20,882
+2,977
+17% +$134K 0.16% 138
2014
Q4
$830K Buy
17,905
+4,314
+32% +$205K 0.16% 138
2014
Q3
$651K Buy
+13,591
New +$660K 0.13% 162

Other funds holding MET

Carnegie Investment Counsel's MET Position: Q1 2026 in Review

Carnegie Investment Counsel reduced its MetLife (MET) stake by 0.71% in Q1 2026, selling an estimated $2.25K and leaving 4,220 shares worth $298K. The position accounts for 0.01% of the portfolio, ranked #482.

Carnegie Investment Counsel first reported a position in MET in Q3 2014 and has held it in 47 quarters since. The position peaked at $2.38M in Q3 2018. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Carnegie Investment Counsel held 4,220 shares of MetLife worth $298K as of Q1 2026.
  • Carnegie Investment Counsel sold 30 MetLife shares in Q1 2026, an estimated $2.25K.
  • MetLife made up 0.01% of Carnegie Investment Counsel's portfolio in Q1 2026, its #482 holding.
  • Carnegie Investment Counsel first reported a position in MetLife in Q3 2014 and has held it in 47 quarters since.
  • Carnegie Investment Counsel's MetLife position peaked at $2.38M in Q3 2018.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Carnegie Investment Counsel's 13F filing for Q1 2026, filed 1 May 2026.